Clinical trials recruiting for Extensive Stage Lung Small Cell Cancer
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin/Cisplatin | 1 |
| Etoposide | 1 |
| Sintilimab (approved) | 1 |
| Tafolecimab | 1 |
| Tarlatamab | 1 |
Self-screener
Recruiting trials
- A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
- Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Related conditions
Trials recruiting for Extensive Stage Lung Small Cell Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Extensive-stage Small Cell Lung Cancer (ES-SCLC) 13Extensive-Stage Small-Cell Lung Cancer 23
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Extensive Stage Lung Small Cell Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.